SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy).

Age Asymptomatic COVID-19 Risk factors SARS-CoV-2 Sex Symptomatic Viral loads

Journal

Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559

Informations de publication

Date de publication:
22 Jun 2021
Historique:
received: 29 12 2020
accepted: 10 06 2021
entrez: 23 6 2021
pubmed: 24 6 2021
medline: 24 6 2021
Statut: epublish

Résumé

In December 2019 an outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 was first observed in Wuhan, China. The virus has spread rapidly throughout the world creating a pandemic scenario. Several risk factors have been identified, such as age, sex, concomitant diseases as well as viral load. A key point is the role of asymptomatic people in spreading SARS-CoV-2. An observational study in Southern Italy was conducted in order to elucidate the possible role of asymptomatic individuals related to their viral loads in the transmission of the virus within two nursing facilities. Oro-nasopharyngeal swabs from 179 nursing health care workers and patients were collected. SARS-CoV-2 RT-qPCR was performed and viral loads were calculated by using standard curve. A statistical correlation between viral loads, the presence/absence of symptoms, age and sex variables was investigated. SARS-CoV-2 was confirmed in the 50.8 % (n = 91) of the cases. Median age of positive individuals resulted higher than negative ones. Over 65 year as well as female individuals showed higher susceptibility to SARS-CoV-2 infection, OR = 3.93 and 2.86, respectively. Among 91 tested positive, the 70.3 % was symptomatic while the 29.7 % was asymptomatic. Median viral loads of asymptomatic individuals were found statistically significant higher than symptomatic ones (p = 0.001), while no influence was observed in age and sex variables. The presence of comorbidities was 8.9 folds higher in patients who showed and developed symptoms compared to non-symptomatic ones. Moreover, higher viral loads were found in patients who remained asymptomatic than pre-symptomatic (p = 0.022). A range from 9.2 to 69 % of confirmed SARS-CoV-2 cases remains asymptomatic, moreover, sporadic transmissions from asymptomatic people are reported, that makes their involvement an important issue to take into account in the spreading control of the virus. An asymptomatic clinical course was observed in the 29.7 % of positive individuals, moreover, median viral loads resulted to be statistically significant when compared to symptomatic ones. Surely, such a relevant frequency should not be ignored in relation to the spread of the disease in an environment which has not only important intrinsic (age, sex, concomitant diseases) but also extrinsic factors such as high population density and close contacts.

Sections du résumé

BACKGROUND BACKGROUND
In December 2019 an outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 was first observed in Wuhan, China. The virus has spread rapidly throughout the world creating a pandemic scenario. Several risk factors have been identified, such as age, sex, concomitant diseases as well as viral load. A key point is the role of asymptomatic people in spreading SARS-CoV-2. An observational study in Southern Italy was conducted in order to elucidate the possible role of asymptomatic individuals related to their viral loads in the transmission of the virus within two nursing facilities.
METHODS METHODS
Oro-nasopharyngeal swabs from 179 nursing health care workers and patients were collected. SARS-CoV-2 RT-qPCR was performed and viral loads were calculated by using standard curve. A statistical correlation between viral loads, the presence/absence of symptoms, age and sex variables was investigated.
RESULTS RESULTS
SARS-CoV-2 was confirmed in the 50.8 % (n = 91) of the cases. Median age of positive individuals resulted higher than negative ones. Over 65 year as well as female individuals showed higher susceptibility to SARS-CoV-2 infection, OR = 3.93 and 2.86, respectively. Among 91 tested positive, the 70.3 % was symptomatic while the 29.7 % was asymptomatic. Median viral loads of asymptomatic individuals were found statistically significant higher than symptomatic ones (p = 0.001), while no influence was observed in age and sex variables. The presence of comorbidities was 8.9 folds higher in patients who showed and developed symptoms compared to non-symptomatic ones. Moreover, higher viral loads were found in patients who remained asymptomatic than pre-symptomatic (p = 0.022).
CONCLUSIONS CONCLUSIONS
A range from 9.2 to 69 % of confirmed SARS-CoV-2 cases remains asymptomatic, moreover, sporadic transmissions from asymptomatic people are reported, that makes their involvement an important issue to take into account in the spreading control of the virus. An asymptomatic clinical course was observed in the 29.7 % of positive individuals, moreover, median viral loads resulted to be statistically significant when compared to symptomatic ones. Surely, such a relevant frequency should not be ignored in relation to the spread of the disease in an environment which has not only important intrinsic (age, sex, concomitant diseases) but also extrinsic factors such as high population density and close contacts.

Identifiants

pubmed: 34158108
doi: 10.1186/s13027-021-00388-x
pii: 10.1186/s13027-021-00388-x
pmc: PMC8218569
doi:

Types de publication

Journal Article

Langues

eng

Pagination

45

Références

Infez Med. 2020 Dec 1;28(4):469-474
pubmed: 33257620
Virology. 2020 Jul;546:122-126
pubmed: 32452410
Indian J Public Health. 2020 Jun;64(Supplement):S139-S141
pubmed: 32496245
Lancet Respir Med. 2020 Sep;8(9):e70
pubmed: 32771081
Crit Care. 2020 Apr 23;24(1):170
pubmed: 32326952
Lancet Infect Dis. 2020 Oct;20(10):1141-1150
pubmed: 32562601
Cell Biosci. 2020 Mar 16;10:40
pubmed: 32190290
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
JAMA Intern Med. 2020 Nov 01;180(11):1447-1452
pubmed: 32780793
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Int J Infect Dis. 2020 Sep;98:180-186
pubmed: 32562846
Thorax. 2021 Jan;76(1):61-63
pubmed: 32963115
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Lancet Infect Dis. 2020 Apr;20(4):411-412
pubmed: 32105638
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Lancet Infect Dis. 2020 Sep;20(9):996-998
pubmed: 32539989
J Med Virol. 2020 Sep;92(9):1634-1636
pubmed: 32190908
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Can J Public Health. 2021 Feb;112(1):12-16
pubmed: 33205377
Emerg Microbes Infect. 2020 Dec;9(1):1546-1553
pubmed: 32608325
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
Infection. 2021 Feb;49(1):117-126
pubmed: 33231841

Auteurs

Lorena Cardillo (L)

Department of Animal Health, Unit of Virology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, 8055, Portici, Naples, Italy.

Claudio de Martinis (C)

Department of Animal Health, Unit of Virology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, 8055, Portici, Naples, Italy. claudio.demartinis@izsmportici.it.

Maurizio Viscardi (M)

Department of Animal Health, Unit of Virology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, 8055, Portici, Naples, Italy.

Claudia Esposito (C)

Department of Animal Health, Unit of Virology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, 8055, Portici, Naples, Italy.

Emanuela Sannino (E)

Department of Animal Health, Unit of Applied Biotechnologies and Bioinformatics, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Naples, Italy.

Gabriella Lucibelli (G)

Department of Animal Health, Unit of Biomolecular Diagnostics, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Naples, Italy.

Antonio Limone (A)

Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Naples, Italy.

Stefania Pellino (S)

Department of Prevention, Azienda Sanitaria Locale (ASL) Benevento, Benevento, Italy.

Rosa Anastasio (R)

Residential and Nursing Home Madonna dell'Arco, Sant'Anastasia, Naples, Italy.

Roberta Pellicanò (R)

Department of Epidemiology and Biostatistic Regional Observatory (OREB), Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Naples, Italy.

Loredana Baldi (L)

Department of Epidemiology and Biostatistic Regional Observatory (OREB), Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Naples, Italy.

Giorgio Galiero (G)

Istituto Zooprofilattico Sperimentale del Mezzogiorno, Portici, Naples, Italy.

Giovanna Fusco (G)

Department of Animal Health, Unit of Virology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, Via Salute, 2, 8055, Portici, Naples, Italy.

Classifications MeSH